PRMT5 and lymphoma: For instance, the type-II protein arginine methyltransferase, PRMT5, activates Wnt signaling and Wnt/ β-CATENIN target gene expression by differentially modulating the promoter occupancy by co-activators and co-repressors in lymphoma cells.